Among the other identified lncRNAs, MEG3 was reported to suppress cell proliferation, invasion, and angiogenesis through the AKT pathway or the transcriptional activity of p53 in breast cancer [23–25, 40, 41]. This evidence concerns the gene TP53 and breast carcinoma.